2014. ISPOR European Congress – Systematic Review of Observational Studies and RCTs of Omalizumab in Severe Persistent Allergic Asthma and Meta-Analysis Feasibility Assessment

Bergrath E, Hwa Ong S, Bousquet J, Balwin M, Manga V, Rao S, Cope S. Systematic Review of Observational Studies and RCTs of Omalizumab in Severe Persistent Allergic Asthma and Meta-Analysis Feasibility Assessment. Value Health. 2014 Nov;17(7):A589. Presented at: ISPOR 17th Annual European Congress; November 8, 2014; Amsterdam, The Netherlands.